Combination of Pembrolizumab and Cabozantinib in Patients With Advanced Sarcomas

NCT05182164 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

119

Enrollment

OTHER

Sponsor class

Conditions

Soft Tissue Sarcoma Adult
Advanced Soft-tissue Sarcoma
Ewing Sarcoma
Osteosarcoma
Undifferentiated Pleomorphic Sarcoma

Interventions

DRUG: Association of pembrolizumab + cabozantinib

Sponsor

Institut Bergonié

Collaborators

[object Object]
[object Object]